Primary bladder carcinoma in situ: Assessment of early BCG response as a prognostic factor

European Urology

Volumn 33, Issue 5, 1998, Pages 457-463

  Orsola, A ^a   Palou, J ^a   Xavier, B ^a   Algaba, F ^a   Salvador, J ^a   Vicente, J ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Bacillus Calmette Guerin (BCG); Bladder neoplasm; Carcinoma in situ (CIS), primary; Prognosis

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA IN SITU; CONFIDENCE INTERVALS; CYSTOSCOPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0031777093     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019635     Document Type: Article

References (28)